Beneficial ownership — 13D / 13G
87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| RIVERNORTH CAPITAL MANAGEMENT, LLC | BYNO byNordic Acquisition Corp | 13G | 16.39% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | BODI Beachbody Company, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | VITL Vital Farms, Inc. | 13G/A | 0.5% | Dec 31, 2023 | 2y |
| EARNEST PARTNERS LLC | CLB Core Laboratories Inc. | 13G/A | 8% | Dec 31, 2023 | 2y |
| GENERATION INVESTMENT MANAGEMENT LLP | RELY Remitly Global, Inc. | 13G/A | 4.15% | Dec 31, 2023 | 2y |
| SPROTT INC. | CTGO Contango Silver & Gold Inc. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | OFIX Orthofix Medical Inc. | 13G | 9.79% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | CPT Camden Property Trust | 13G/A | 7.24% | Dec 31, 2023 | 2y |
| RGM Capital, LLC | AVNS Avanos Medical, Inc. | 13G/A | 6.83% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | HOOK HOOKIPA Pharma Inc. | 13G/A | 1.1% | Dec 31, 2023 | 2y |
| EdgePoint Investment Group Inc. | BERY Berry Global Group, Inc. | 13G/A | 10.1% | Dec 31, 2023 | 2y |
| FRONTIER CAPITAL MANAGEMENT CO.,LLC | MRC MRC GLOBAL INC. | 13G | 7.12% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | NYT New York Times Co | 13G | 5.6% | Dec 31, 2023 | 2y |
| Bares Capital Management, Inc. | SSTI Soundthinking, Inc. | 13G | 5.81% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | ALGS Aligos Therapeutics, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | BFAC Battery Future Acquisition Corp. | 13G | 6.77% | Dec 31, 2023 | 2y |
| COMPASS GROUP LLC | VTRU Vitru Limited Common Shares | 13G/A | 14.1% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | ARYD ARYA Sciences Acquisition Corp IV Class A Odinary Shares | 13G | 6.44% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | MORF Morphic Holding, Inc. Common Stock | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares | 13G | 9.46% | Dec 31, 2023 | 2y |
| Deer IX & Co. L.P. | ACVA ACV Auctions Inc. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | KZIA Kazia Therapeutics Ltd | 13G | 9.99% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | CCTSF Cactus Acquisition Corp. 1 Ltd | 13G/A | 0% | Dec 31, 2023 | 2y |
| 22NW Fund, LP | PFX PhenixFIN Corp | 13G/A | 5.7% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | MRNS Marinus Pharmaceuticals, Inc | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | GMFI Aetherium Acquisition Corp. Class A Common Stock | 13G/A | 6.54% | Dec 31, 2023 | 2y |
| GREENLIGHT CAPITAL INC | CNR Core Natural Resources, Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | FOLD AMICUS THERAPEUTICS, INC. | 13G/A | 9.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BLBD Blue Bird Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | OCAX OCA Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| ENDEAVOUR CAPITAL ADVISORS INC | USCB Uscb Financial Holdings, Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | PRTA Prothena Corp Public Ltd Co | 13G/A | 7.9% | Dec 31, 2023 | 2y |
| Abdiel Qualified Master Fund, LP | GLBE Global-E Online Ltd. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| HG Vora Capital Management, LLC | R Ryder System Inc | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | SHFS SHF Holdings, Inc. | 13G/A | 0.3% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | ACRS Aclaris Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | MRT Marti Technologies, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| EW Healthcare Partners Fund 2 GP, L.P. | TELA TELA Bio, Inc. | 13G | 16.79% | Dec 31, 2023 | 2y |
| MORGAN STANLEY | AOMR Angel Oak Mortgage REIT, Inc. | 13G/A | 20.7% | Dec 31, 2023 | 2y |
| Thomas A. Satterfield, Jr. | ARKR Ark Restaurants Corp | 13G/A | 14.86% | Dec 31, 2023 | 2y |
| Antara Capital LP | XAGE Longevity Health Holdings, Inc. | 13G/A | 1.6% | Dec 31, 2023 | 2y |
| BECK MACK & OLIVER LLC | TSQ Townsquare Media, Inc. | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Aristotle Capital Management, LLC | LEN Lennar Corp | 13G/A | 4.32% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | IDAI T Stamp Inc | 13G | 9.99% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | COGT Cogent Biosciences, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Kaufman Micha | FVRR Fiverr International Ltd. | 13G/A | 7% | Dec 31, 2023 | 2y |
| Sanders Capital, LLC | STX Seagate Technology Holdings plc | 13G/A | 7.41% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | NIR Near Intelligence, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Commodore Capital LP | SABS SAB Biotherapeutics, Inc. | 13G/A | 3.5% | Dec 31, 2023 | 2y |
| Alain Bédard | TFII TFI International Inc. | 13G/A | 6% | Dec 31, 2023 | 2y |